Account
ZenithOptimedia wins media duties of Yatra.com worth Rs 300 million
Indiantelevision.com and Spatial Access Private Limited‘ newsletter — ‘Ad Accounts Action‘ — that will keep you abreast with all the creative and media accounts changing hands in the industry. Spatial Access Private Limited (SAPL) is India‘s first media audit firm and hence, has a keen eye on all movements in the space. ‘Ad Accounts Action‘ is brought to you once every fortnight. Given below is a listing of accounts that moved in the period 1 March 2012- 14 March 2012. |
Account name | Incumbent | New agency | Reported annual spends in Rs |
| Media | |||
| Crazeal [Groupon India Unit] | Lintas Initiative Mediai | 250 million | |
| Henkel | Lintas Media Group | NA | |
| DDB Mudra Max | |||
| Mango [Lifestyle] | OMD India | NA | |
| Star Health | Lodestar UM | OMD India | 100-120 million |
| Yatra.com | Motivator | ZenithOptimedia | 300 million |
| Creative | |||
| Andslite [Solar & LED Products] | What The Hell [Delhi] | 100 million | |
| Ditto TV | Percept/H | 150 million | |
| Ma Foi Randstad | Ogilvy India [Chennai] | 50-100 million | |
| Micromax forthcomming assignment | Taproot india | NA | |
| MSM‘s upcomming sports cahnnel | Euro RSCG | NA | |
| Nirlep [Kitchen Appliances] | McCann Erickson | Curry-Nation [Mumbai] | 50 million |
| Renaissance | Onads Communications [Mumbai] | NA | |
| Tatva edible oils | AMO Communications [Delhi] | NA | |
| Tetra Pak India | Grey | Dentsu India | 100-120 million |
| Information compiled for period 1 Mar 2012 -14 Mar 2012 by Spatial Access Private Limited, India‘s first Media Audit & Advisory. For information or clarifications email : info@spatialaccess.com, www.spatialaccess.com | |||
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
